Acetyl-CoA metabolism as a therapeutic target for cancer - 11/11/23


Abstract |
Acetyl-coenzyme A (acetyl-CoA), an essential metabolite, not only takes part in numerous intracellular metabolic processes, powers the tricarboxylic acid cycle, serves as a key hub for the biosynthesis of fatty acids and isoprenoids, but also serves as a signaling substrate for acetylation reactions in post-translational modification of proteins, which is crucial for the epigenetic inheritance of cells. Acetyl-CoA links lipid metabolism with histone acetylation to create a more intricate regulatory system that affects the growth, aggressiveness, and drug resistance of malignancies such as glioblastoma, breast cancer, and hepatocellular carcinoma. These fascinating advances in the knowledge of acetyl-CoA metabolism during carcinogenesis and normal physiology have raised interest regarding its modulation in malignancies. In this review, we provide an overview of the regulation and cancer relevance of main metabolic pathways in which acetyl-CoA participates. We also summarize the role of acetyl-CoA in the metabolic reprogramming and stress regulation of cancer cells, as well as medical application of inhibitors targeting its dysregulation in therapeutic intervention of cancers.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Acetyl-CoA metabolic enzymes are extensively dysregulated in cancer. |
• | Acetyl-CoA links cell metabolism and protein acetylation in cancer. |
• | Dysregulated acetyl-CoA metabolism contributes to hallmarks of cancer progression. |
• | Targeting acetyl-CoA metabolism is an efficient approach for cancer treatment. |
Abbreviation : ACAT1, ACC1, ACC2, acetyl-CoA, ACLY, ACOT12, ACSS1, ACSS2, AML, AMPK, ATP, BC, BCAA, BCCP, BCL2, BECN1, BDH1, BET, BRCA1, CBP, CDK5, CoQ, CPT2, CrAT, CS, CT, CTCL, DCA, DHL/THL, EED, EMT, EP300, ERK, EWS, FAO, FASN, FDA, FFA, FPP, GBM, GCN5, HAT, HCA, HDAC, HDACi, HMGCL, HMGCS2, HMG-CoA, HMGCR, HMGCS, IDH1, KAT, LCFA, LIFR, MUFA, MVA, MYST, NAD, NADH, NADPH, NAT, NCOA, OGT, PC, PCAF, PCD, PDA, PDC, PDK, PIK3C3, PTCL, PTEN, PUFA, ROS, SFA, SIRT2, SLC25A1, SLC25A20, SLC33A1, SQSTM1, SREBP, TCA, TCGA, TF, Tip60, ULK1, YEATS
Keywords : Acetyl-coenzyme A metabolism, Metabolic reprogramming, Protein acetylation, Cancer progression, Cancer therapy
Plan
Vol 168
Article 115741- décembre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?